Implant Sciences Announces Results of 2015 Annual Shareholder Meeting
WILMINGTON, Mass., July 7, 2015 /PRNewswire/ — Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it held its annual shareholders meeting on July 1, 2015 at its headquarters in Wilmington, MA.
At this meeting, the company’s shareholders approved each proposal presented, including the election of the Director nominees to the Board of Directors. The Board and Implant Sciences’ management believes this outcome conveys investor confidence in the current direction of the company.
James M. Simon, Jr. has been elected as an independent member of the Implant Sciences Board of Directors and Michael C. Turmelle, an existing independent director, has been elected as Chairman of the Board of Directors. Dr. Bill McGann and Robert Liscouski, Implant Sciences’ Chief Executive Officer and Executive Vice President, Business Development, respectively, were also elected and will continue to serve on the Board. The final voting results of the Annual Meeting will be made available publicly in a Form 8-K to be filed with the Securities and Exchange Commission.
“We are very pleased with the outcome of the shareholders meeting,” stated Michael Turmelle, Implant Sciences’ Chairman of the Board. “We believe that our significant progress in the marketplace, as demonstrated by the numerous ECAC wins over the competition, continues to bolster our confidence, which is shared by our shareholders and investors, that Implant Sciences is now a major force in the marketplace.”
“During the shareholders meeting, management was pleased to convey to our shareholders our confidence in our manufacturing capacity and in the delivery schedules set forth in contracts with the TSA and EU airports. Our production team has been planning for our success in the marketplace and we are pleased to be able to deliver on the growing demand for our products,” stated Dr. McGann.